Phoenix Financial’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,000
Closed -$237K 381
2024
Q3
$237K Sell
4,000
-380,444
-99% -$21.7M ﹤0.01% 318
2024
Q2
$21.5M Buy
384,444
+338,390
+735% +$18.9M 0.33% 55
2024
Q1
$2.7M Buy
+46,054
New +$2.6M 0.04% 171
2022
Q4
Sell
-33,900
Closed -$1.6M 310
2022
Q3
$1.6M Hold
33,900
0.04% 166
2022
Q2
$1.71M Hold
33,900
0.04% 182
2022
Q1
$2.07M Sell
33,900
-24,000
-41% -$1.43M 0.03% 191
2021
Q4
$3.81M Buy
57,900
+13,398
+30% +$858K 0.06% 140
2021
Q3
$2.79M Buy
+44,502
New +$2.84M 0.05% 178
2021
Q2
Sell
-109,098
Closed -$6.01M 356
2021
Q1
$6.01M Buy
109,098
+41,880
+62% +$2.32M 0.14% 135
2020
Q4
$3.66M Buy
67,218
+4,218
+7% +$220K 0.1% 159
2020
Q3
$2.96M Sell
63,000
-44,262
-41% -$2.14M 0.12% 124
2020
Q2
$4.5M Sell
107,262
-16,902
-14% -$722K 0.19% 114
2020
Q1
$4.55M Buy
124,164
+59,022
+91% +$2.49M 0.23% 109
2019
Q4
$2.85M Sell
65,142
-12,042
-16% -$506K 0.12% 126
2019
Q3
$3M Buy
+77,184
New +$3.16M 0.14% 113

Other funds holding IHI

Phoenix Financial's IHI Position: Q4 2024 in Review

Phoenix Financial sold out of iShares US Medical Devices ETF (IHI) in Q4 2024, closing a stake of 4,000 shares — an estimated $237K sold.

Phoenix Financial first reported a position in IHI in Q3 2019 and held it in 15 quarters. The position peaked at $21.5M in Q2 2024. 566 funds tracked by Wall St. Rank hold IHI as of Q4 2024.

  • Phoenix Financial reported no remaining iShares US Medical Devices ETF position as of Q4 2024 after selling out during the quarter.
  • Phoenix Financial sold 4,000 iShares US Medical Devices ETF shares in Q4 2024, an estimated $237K.
  • Phoenix Financial first reported a position in iShares US Medical Devices ETF in Q3 2019 and held it in 15 quarters.
  • Phoenix Financial's iShares US Medical Devices ETF position peaked at $21.5M in Q2 2024.
  • 566 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2024.

Based on Phoenix Financial's 13F filing for Q4 2024, filed 13 Feb 2025.